Treatment Innovations

A Controversial Lifeline: Replimune’s RP1 Clears Major Regulatory Hurdle Despite FDA Skepticism

• Treatment Innovations

A Controversial Lifeline: Replimune’s RP1 Clears Major Regulatory Hurdle Despite FDA Skepticism

Nana July 31, 2026

By Jonathan Gardner Published July 30, 2026 In a high-stakes showdown that highlighted the growing tension between...

Read More Read more about A Controversial Lifeline: Replimune’s RP1 Clears Major Regulatory Hurdle Despite FDA Skepticism

The Science of Velocity: How Sai Life Sciences is Rewriting the Playbook for Drug Development

• Treatment Innovations

The Science of Velocity: How Sai Life Sciences is Rewriting the Playbook for Drug Development

Neng Nana July 30, 2026

The pharmaceutical industry is currently facing an existential reckoning with time. For decades, the standard path to...

Read More Read more about The Science of Velocity: How Sai Life Sciences is Rewriting the Playbook for Drug Development

Baxter International Reports Resurgent Q2 2026: A Strategic Pivot Toward Recovery

• Treatment Innovations

Baxter International Reports Resurgent Q2 2026: A Strategic Pivot Toward Recovery

Lina Hope July 30, 2026

Baxter International, the Illinois-based medical technology giant, has officially turned the page on a tumultuous period of...

Read More Read more about Baxter International Reports Resurgent Q2 2026: A Strategic Pivot Toward Recovery

Innovation at the Intersection of Science: A Preview of AAPS PharmSci 360 2026

• Treatment Innovations

Innovation at the Intersection of Science: A Preview of AAPS PharmSci 360 2026

Nana Wu July 30, 2026

The pharmaceutical industry stands at a critical juncture, where the convergence of advanced computational modeling, artificial intelligence...

Read More Read more about Innovation at the Intersection of Science: A Preview of AAPS PharmSci 360 2026

CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

• Treatment Innovations

CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

Asep Darmawan July 30, 2026

In a significant move for the cardiovascular medtech sector, Massachusetts-based CoreMap has successfully closed a $37 million...

Read More Read more about CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

GSK Unveils Massive £1.9 Billion Restructuring Plan to Counter Patent Cliff and Fuel Innovation

• Treatment Innovations

GSK Unveils Massive £1.9 Billion Restructuring Plan to Counter Patent Cliff and Fuel Innovation

Lina Irawan July 30, 2026

By Delilah Alvarado | July 28, 2026 In a decisive maneuver to insulate its future profitability from...

Read More Read more about GSK Unveils Massive £1.9 Billion Restructuring Plan to Counter Patent Cliff and Fuel Innovation

The Evolution of Oncology Intelligence: How ConcertAI is Transforming CancerLinQ into a Point-of-Care Powerhouse

• Treatment Innovations

The Evolution of Oncology Intelligence: How ConcertAI is Transforming CancerLinQ into a Point-of-Care Powerhouse

Layla Zulfa July 30, 2026

In the high-stakes world of oncology, the distance between a breakthrough discovery in a laboratory and the...

Read More Read more about The Evolution of Oncology Intelligence: How ConcertAI is Transforming CancerLinQ into a Point-of-Care Powerhouse

AI-Driven Diagnostic Breakthrough: CorVista Secures FDA Clearance for Non-Invasive Heart Failure Assessment

• Treatment Innovations

AI-Driven Diagnostic Breakthrough: CorVista Secures FDA Clearance for Non-Invasive Heart Failure Assessment

Azzam Bilal Chamdy July 30, 2026

In a significant leap forward for cardiovascular medicine, CorVista Health has received US Food and Drug Administration...

Read More Read more about AI-Driven Diagnostic Breakthrough: CorVista Secures FDA Clearance for Non-Invasive Heart Failure Assessment

Pharma Earnings Pulse: Biogen’s Resilience, AstraZeneca’s Ambitious Pivot, and GSK’s Oncology Bet

• Treatment Innovations

Pharma Earnings Pulse: Biogen’s Resilience, AstraZeneca’s Ambitious Pivot, and GSK’s Oncology Bet

Jia Lissa July 30, 2026

As the pharmaceutical industry navigates the midpoint of 2026, the latest quarterly earnings season offers a critical...

Read More Read more about Pharma Earnings Pulse: Biogen’s Resilience, AstraZeneca’s Ambitious Pivot, and GSK’s Oncology Bet

The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research

• Treatment Innovations

The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research

Neng Nana July 30, 2026

In the high-stakes world of pharmaceutical R&D, the battle for drug discovery supremacy has shifted from the...

Read More Read more about The Arms Race in Silicon: How Bristol Myers Squibb’s New AI Supercomputer Redefines Pharma Research